Share your requirements to help us to customize the report.
   I acknowledge that I have read the Privacy Policy
Confidentiality

We respect your privacy rights and safeguard your personal information. We prevent the disclosure of personal information to third parties.

Analyst Support
$5,300
BUY NOW GET FREE SAMPLE

FAQs

NGS Automation Market was valued at USD 1273.2 million in 2019, and it is expected to reach a value of USD 3355.94 million in 2019, at a CAGR of 14.85% over the forecast period (2024-2031).

The competitive landscape for the next-generation sequencing (NGS) market includes information by competitor. An overview of the business, financials, revenue generated, market potential, investments in R&D, new market initiatives, production facilities, company strengths and weaknesses, product launches, product approval pipelines, product approvals, patents, product width and breadth, application dominance, and technology lifeline curve are among the details provided. The data metrics mentioned above only pertain to the company's market focus on next-generation sequencing (NGS). 'Agilent Technologies', 'Bio-Rad Laboratories Inc.', 'DNASTAR Inc.', 'Eurofins Scientific', 'Hoffmann-La Roche Ltd', 'Illumina Inc.', 'Danaher Corporation (IDT)', 'Pacific Biosciences of California Inc.', 'PerkinElmer Inc.', 'Qiagen', 'Thermo Fisher Scientific Inc.'

The increased demand for automation in NGS workflow, the prevalence of cancer, rising R&D spending, and rising healthcare costs are just a few of the reasons contributing to the expansion of this industry. Additionally, this market is anticipated to experience significant expansion due to the expanding uses of next-generation sequencing and the growing number of corporate partnerships to create library preparation techniques.

Automation of NGS library preparation enables dependable and repeatable data creation by assisting researchers in library quality improvement and consistent yields. It also improves productivity and lowers costs. Reducing manual contact with the reagents and samples significantly lowers the risk of contamination. As a result, the market for NGS automation is anticipated to be driven by the rising demand for automation in NGS workflow.

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). The NGS automation market is expected to be dominated by North America, followed by Europe and Asia-Pacific. The significant market share held by North America is due in large part to the region's high R&D expenditures, growing demand for NGS automation in the pharmaceutical and biotech sectors, and expanding government support and investment in the region's genome sequencing infrastructure.

Feedback From Our Clients

Global NGS Automation Market

Product ID: SQMIG35A2270

$5,300
BUY NOW GET FREE SAMPLE